Inhibiting SLC16A1 can significantly suppress the proliferation, migration and invasion of bladder cancer cells, and SLC16A1 promotes the progression of bladder cancer by affecting epithelial mesenchymal transformation and glycolysis (28). This evidence concerns the gene SLC16A1 and urinary bladder cancer.